4//SEC Filing
Flanagan W. Michael 4
Accession 0001599901-25-000223
CIK 0001599901other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 8:30 AM ET
Size
6.9 KB
Accession
0001599901-25-000223
Insider Transaction Report
Form 4
Flanagan W. Michael
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-12-17+27,500→ 107,695 total - Tax Payment
Common Stock
2025-12-17$71.87/sh−13,695$984,260→ 94,000 total
Footnotes (2)
- [F1]Represents shares acquired upon the vesting of performance-based restricted stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer's common stock. The PSUs were originally granted to the Reporting Person on October 30, 2024. The PSUs were accelerated and settled on December 17, 2025 for tax planning purposes and such shares remain subject to recoupment by the Issuer if the Reporting Person's employment is terminated by the Issuer for cause or by the Reporting Person without good reason.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding in connection with the settlement of PSUs on December 17, 2025.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001841990
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 8:30 AM ET
- Size
- 6.9 KB